Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Central Nervous System Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00014105
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Atlantic Health System
Early research (Phase 1)Study completedNCT00036894
What this trial is testing

CC-5013 in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Early research (Phase 1)WithdrawnNCT02145910
What this trial is testing

Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases

Who this might be right for
Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)WithdrawnNCT03973879
What this trial is testing

Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma
Darell Bigner
Very early researchLooking for participantsNCT03122197
What this trial is testing

Study of Letrozole in Recurrent Gliomas

Who this might be right for
Brain Tumor
University of Cincinnati 39
Testing effectiveness (Phase 2)Study completedNCT01290263
What this trial is testing

Amgen 386 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Dana-Farber Cancer Institute 48
Testing effectiveness (Phase 2)Study completedNCT00003301
What this trial is testing

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Early research (Phase 1)Study completedNCT00003712
What this trial is testing

CCI-779 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
The University of Texas Health Science Center at San Antonio 15
Testing effectiveness (Phase 2)Study completedNCT00006119
What this trial is testing

Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma

Who this might be right for
Brain and Central Nervous System Tumors
UNICANCER
Not applicableStudy completedNCT07722286
What this trial is testing

Relapse and Functional Outcomes in Anti-LGI1 Encephalitis

Who this might be right for
Autoimmune EncephalitisLGI1 EncephalitisLimbic Encephalitis
Shen Chun-Hong 112
Testing effectiveness (Phase 2)Ended earlyNCT00616642
What this trial is testing

Rosiglitazone in Treating Patients With Pituitary Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00619112
What this trial is testing

Temozolomide in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Recurrent Central Nervous System Neoplasm
University of California, San Francisco 60
Large-scale testing (Phase 3)Study completedNCT00377156
What this trial is testing

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Who this might be right for
Breast CancerCognitive/Functional EffectsLung Cancer+2 more
Alliance for Clinical Trials in Oncology 213
Testing effectiveness (Phase 2)Study completedNCT03484702
What this trial is testing

Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Celgene 113
Large-scale testing (Phase 3)Study completedNCT00118222
What this trial is testing

High Light and Low Light Dose PDT in Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Case Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT00813592
What this trial is testing

Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma

Who this might be right for
Cancer
University of Utah 2
Early research (Phase 1)Study completedNCT03206021
What this trial is testing

COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid Tumors

Who this might be right for
Recurrent Childhood CNS TumorEpendymoma, Recurrent ChildhoodChildhood Solid Tumor
The Hospital for Sick Children 31
Not applicableStudy completedNCT01706432
What this trial is testing

Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

Who this might be right for
Central Nervous System MetastasesInvasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma With Predominant Intraductal Component+13 more
University of Chicago 4
Early research (Phase 1)Study completedNCT00003463
What this trial is testing

Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Not applicableLooking for participantsNCT05124912
What this trial is testing

REMASTer: REcurrent Brain Metastases After SRS Trial

Who this might be right for
Brain MetastasesRadiation NecrosisRecurrent Tumor+1 more
Monteris Medical 261
Next Page